Drug class

Gallstone Solubilizing Agents

Gallstone solubilizing agents, also known as cholelitholytic bile acid therapies, are a specialized therapeutic class of naturally occurring bile acids, primarily including ursodiol and chenodiol. Read more about Gallstone Solubilizing Agents

28 drugs in this class 27 manufacturers

Advertisement

Drugs in Gallstone Solubilizing Agents

Showing 1–9 of 28 drugs

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
AHP

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
AVKARE

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
Lannett Company

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
EPIC PHARMA LLC

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · PRIMARY BILIARY CHOLANGITIS
GLENMARK PHARMA

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · PRIMARY BILIARY CHOLANGITIS
PAR HEALTH USA,

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
GSK Consumer Healthcare

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
BLU PHARMACEUTI
Filter & compare in the drug finder → Opens the drug finder with Gallstone Solubilizing Agents preselected. Add indication or manufacturer filters there.

About Gallstone Solubilizing Agents.

Gallstone solubilizing agents, also known as cholelitholytic bile acid therapies, are a specialized therapeutic class of naturally occurring bile acids, primarily including ursodiol and chenodiol.

They function primarily by decreasing hepatic secretion and synthesis of cholesterol and reducing intestinal cholesterol absorption, which desaturates biliary cholesterol and facilitates the gradual dispersion and dissolution of cholesterol gallstones.

Clinically, these agents are utilized for the medical dissolution of small, radiolucent, non-calcified gallstones in patients who are non-surgical candidates, as well as for the prevention of gallstone formation during rapid weight loss.

Additionally, select agents within this class are indicated for chronic cholestatic hepatobiliary conditions, particularly primary biliary cholangitis.